RecruitingNot ApplicableNCT07088250

Statins for Treatment of Primary Intracerebral Hemorrhage

Statins for Treatment Of Primary IntraCerebral Hemorrhage (STOP ICH)

Sponsor

The Second Hospital of Anhui Medical University

Enrollment

264 participants

Start Date

May 6, 2023

Study Type

INTERVENTIONAL

Conditions

Cerebrovascular Disorders Intracranial Hemorrhages Intracerebral haemorrhage Intracranial Hemorrhage

Summary

The STOP ICH trial is a multicenter, prospective, randomized, open-label, blinded end-point (PROBE) study designed to assess the efficacy and safety of atorvastatin in patients with intracerebral hemorrhage (ICH) presenting within 3 to 24 hours of symptom onset.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Atorvastatin Treatment and Best Medical Treatment for people with cerebrovascular disorders, intracerebral haemorrhage, and other related conditions. The study is currently recruiting participants at 22 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAtorvastatin Treatment

Atorvastatin 20 mg once daily for 21 days.

OTHERBest Medical Treatment

Patients in this group will receive best medical treatments in accordance with the guideline-directed management for ICH.

Locations(22)

Anqing First People's Hospital of Anhui Province

Anqing, Anhui, China

Fuyang City Sixth People's Hospital

Fuyang, Anhui, China

Fuyang Hospital of Anhui Medical University

Fuyang, Anhui, China

Fuyang People's Hospital

Fuyang, Anhui, China

Hefei Eighth People's Hospital

Hefei, Anhui, China

Hefei First People's Hospital

Hefei, Anhui, China

The Second Hospital of Anhui Medical University

Hefei, Anhui, China

Huainan Xinhua Hospital

Huainan, Anhui, China

The First Affiliated Hospital of Anhui University of Science and Technology (Huainan First People's Hospital)

Huainan, Anhui, China

Huoqiu First People's Hospital

Lu'an, Anhui, China

Shucheng People's Hospital

Lu'an, Anhui, China

Si County People's Hospital

Suzhou, Anhui, China

The First Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China

Kaifeng Central Hospital

Kaifeng, Henan, China

Xihua County People's Hospital

Zhoukou, Henan, China

Xiangyang Hospital of Traditional Chinese Medicine

Xiangyang, Hubei, China

The First People's Hospital of Chenzhou

Chenzhou, Hunan, China

Yancheng First People's Hospital

Yancheng, Jiangsu, China

Chengdu Western Hospital

Chengdu, Sichuan, China

Panzhihua Central Hospital

Panzhihua, Sichuan, China

Dazhu County People's Hospital

Dazhou, Sizhuan, China

The Third Affiliated Hospital of Chong Qing Medical University

Chongqing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07088250

Related Trials

Clinical Study to Evaluate the Efficacy of Febuxostat in the Treatment of Conservatively Managed Intracranial Hemorrhage Patients

NCT077015121 location

NICardipine for Fast Achievement of Systolic BP Targets in ICH

NCT070442321 location

Effectiveness of Best Care Practices in Acute Stroke in Conventional Hospitalization (BEST CARE ICTUS_HC)

NCT076273994 locations

International Care Bundle Evaluation in Cerebral Hemorrhage Research

NCT0642933254 locations

Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Stroke Survivors

NCT074147322 locations